Press Release Description

Global Theranostics Market to Record a Substantial CAGR of Around 14.4% During 2024-30

The Global Theranostics Market is anticipated to grow at a CAGR of about 14.4% during the forecast period of 2024-30, cites MarkNtel Advisors in the recent research report. The Global Theranostics Market is experiencing a rapid growth rate driven by a notable trend, i.e., increased collaboration among companies aiming to elevate patient care. These partnerships are not only transforming the landscape of healthcare but are also amplifying the recognition and adoption of theranostics worldwide. The focus of these collaborations is strategically designed to fortify research endeavors, foster clinical partnerships, and cultivate educational initiatives in the realm of theranostics. These strategic alliances serve a multifaceted purpose. They aim to enhance awareness among consumers and healthcare professionals regarding the profound benefits and effectiveness of theranostics.

Furthermore, they respond to the escalating demand for theranostics practices, particularly following the approval of new theranostics-related drugs and therapies. These collaborations also strive to enhance technologies for improved image quality and care coordination and educate healthcare practitioners and government bodies to drive theranostics adoption and advancement.

Moreover, the integration of artificial intelligence (AI) in diagnostics has significantly enhanced accuracy and efficiency, further fueling the adoption of theranostics. With recent FDA approvals validating its efficacy, theranostics is poised to revolutionize personalized medicine, ensuring that patients receive tailored treatments based on their molecular and cellular profiles. In the realm of cancer management, theranostics and precision medicine have emerged as indispensable tools, enabling healthcare professionals to identify specific biomarkers and tailor treatments accordingly. This personalized approach not only increases treatment success rates but also minimizes unnecessary interventions, improves disease monitoring, and potentially reduces overall healthcare costs.

Global Theranostics Market

As the healthcare landscape continues to evolve towards tailored approaches, the demand for theranostics is expected to soar. Its ability to precisely identify molecular targets, particularly in diseases like tumors, aligns perfectly with the growing demand for personalized medicines, presenting a significant growth opportunity for the market in the foreseeable future, further states the research report, “Global Theranostics Market Analysis, 2024.”

Global Theranostics Market Segmentation Analysis

The Polymerase Chain Reaction (PCR) Segment Holds a Major Market Share

Based on the product, the market is further bifurcated into diagnostic imaging, radiopharmaceuticals, IVD/biomarkers screening, software & services. The polymerase chain reaction (PCR) segment under IVD/biomarkers screening has shown rapid growth in the past few years and is anticipated to be in the same trend in the forecast period as well. Particularly, the rising demand for swift and precise diagnostic tests across diverse medical fields fuels this trajectory. PCR's versatility and accuracy make it indispensable in diagnosing a wide range of diseases, from infectious illnesses to genetic disorders.

Moreover, continuous advancements in PCR-based technologies, such as digital PCR and droplet digital PCR, are revolutionizing diagnostic capabilities, enhancing sensitivity and specificity, and enabling high-throughput testing. With healthcare systems worldwide prioritizing early diagnosis and personalized treatment strategies, the PCR segment is expected to assume a pivotal role in driving innovation and shaping the future of theranostics.

North America Leads the Global Theranostics Market

Geographically, North America is leading the theranostics industry, primarily propelled by the escalating demand for enhanced and personalized treatment options. This demand surge is notably driven by the increasing incidence of cancer cases across the region, necessitating more effective and tailored therapeutic approaches. Theranostics emerges as a pivotal solution in this scenario, leveraging advanced diagnostic techniques to identify specific biomarkers associated with various cancers. By doing so, theranostics empowers clinicians to administer targeted therapies precisely tailored to each patient's unique molecular profile, thus addressing the pressing need for personalized cancer care in North America.

Furthermore, the growing popularity of personalized medicine techniques further amplifies the demand for theranostics in the region. With a shifting focus towards customizing treatment regimens based on individual genetic compositions, disease characteristics, and biomarker profiles, theranostics assumes a central role in this paradigm shift. By providing clinicians with invaluable insights into the molecular mechanisms driving disease progression, theranostics facilitates the development of highly personalized treatment strategies. This convergence of advanced diagnostics, targeted therapies, and personalized medicine principles underscores the critical role of theranostics in reshaping the landscape of cancer care in North America, ensuring the region's continued dominance in the theranostics industry.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Siemens Healthcare Private Limited, GE HealthCare, Bayer AG, Cardinal Health, Hologic, Inc., Radiopharm Theranostics Limited, ITM Isotope Technologies Munich SE, Isotopia Molecular Imaging, Perspective Therapeutics, Ratio Therapeutics, ChiRhoClin, Cerebral Therapeutics, Inc., Telix Pharmaceuticals Limited, Biosynth Ltd., Theradiag, and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

  1. What are the industry’s overall statistics or estimates (Overview, Market Size- By Value, Forecast Numbers, Segmentation, Market Shares)?
  2. What are the market trends influencing the current scenario of the market?
  3. What key factors would propel and impede the industry across the globe?
  4. How has the industry been evolving in terms of geography & product adoption?
  5. How has the competition been shaping up across the regions?
  6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
  7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,700

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 4,850

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 6,000

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 7,500

Need Assistance?


[email protected]
100% Safe & Secure

Strongest encryption on the website to make your purchase safe and secure